Semiconductor Exposure Hits 18% of S&P 500 This Year
The S&P 500 now carries an 18% semiconductor exposure, a level unseen since the dot-com era. A handful of chipmakers ...
Which Rewards Credit Card Has The Best Benefits
Uncover the rewards credit card that offers the best benefits to enhance your financial experience.
28,009 articlesBerkshire Hathaway Sold Stocks: 16 Exits, 70% in 7 Holdings
Berkshire Hathaway sold stocks in Q1, exiting 16 positions as the conglomerate maintains a heavy concentration in sev...
Boise Cascade Stock Down: Insider Sells $27 Million Move
A large insider stake reduction coincided with Boise Cascade stock down, prompting questions about valuation and risk...
Worth Investing Ethereum (ETH) Right Now: A 2026 View
Ethereum’s bounce prospects hinge on institutional access and policy clarity. A new staking ETF and rising regulatory...
Domicile Change That Cuts a Pension Tax Bill to Zero
Retirees with large pensions are exploring domicile changes to Florida and other states to wipe out California state ...
Amazon’s CFO Shatters Expectations, Tops Fortune 500
Amazon dethroned Walmart to take the No. 1 spot on the Fortune 500 as revenue surged in 2025. CFO Brian Olsavsky stee...
Synergy Merge with APM Creates Large Mortgage Platform
Synergy One Lending will merge into American Pacific Mortgage, forming a large nationwide platform with roughly $14 b...
Inflation First Time Since 2023 Sparks Fed Reassessment
U.S. inflation climbs above 4% for the first time since 2023, renewing pressure on the Fed and prompting traders to r...
Brands Integra Earns GameChanger Nod Amid 65% Growth Surge
Brands By Integra has earned a 2026 GameChanger nod after delivering a 65% jump in transaction sides from 2021 to 202...
Trump Says U.S. Reached Historic Peace Deal with Iran
President Donald Trump announced a peace deal with Iran, triggering sharp moves in oil, stocks, and currencies as inv...
Mercadolibre Stock After Insider: Is It Worth a Buy?
A senior MercadoLibre executive recently disclosed an open-market purchase, prompting questions about what this means...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status